HALOZYME THERAPEUTICS, INC. - Common Stock (HALO)

CUSIP: 40637H109

Q1 2022 13F Holders as of 31 Mar 2022

Type / Class
Equity / Common Stock
Shares outstanding
123,650,000
Total 13F shares
128,337,653
Share change
-1,053,464
Total reported value
$5,115,592,058
Put/Call ratio
20%
Price per share
$39.88
Number of holders
298
Value change
-$42,336,732
Number of buys
129
Number of sells
156

Sponsored

Quarterly Holders Quick Answers

What is CUSIP 40637H109?
CUSIP 40637H109 identifies HALO - HALOZYME THERAPEUTICS, INC. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of HALO - HALOZYME THERAPEUTICS, INC. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
BlackRock Finance, Inc.
13F
Company
16%
19,439,863
$781,676,000 31 Dec 2021
13F
VANGUARD GROUP INC
13F
Company
11%
13,495,913
$542,670,000 31 Dec 2021
13F
Artisan Partners Limited Partnership
13F
Company
7.7%
9,505,768
$382,227,000 31 Dec 2021
13F
STATE STREET CORP
13F
Company
4.7%
5,860,832
$235,664,000 31 Dec 2021
13F
Invesco Ltd.
13F
Company
4.5%
5,506,233
$221,406,000 31 Dec 2021
13F
JPMORGAN CHASE & CO
13F
Company
4.1%
5,126,301
$206,129,000 31 Dec 2021
13F
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC
13F
Company
4.1%
5,073,665
$204,012,000 31 Dec 2021
13F
SNYDER CAPITAL MANAGEMENT L P
13F
Company
3.3%
4,064,779
$163,445,000 31 Dec 2021
13F
MACQUARIE GROUP LTD
13F
Company
2.5%
3,072,956
$123,564,000 31 Dec 2021
13F
GOLDMAN SACHS GROUP INC
13F
Company
2.2%
2,765,247
$111,191,000 31 Dec 2021
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
2%
2,474,566
$99,502,000 31 Dec 2021
13F
NORTHERN TRUST CORP
13F
Company
1.9%
2,300,973
$92,522,000 31 Dec 2021
13F
LOOMIS SAYLES & CO L P
13F
Company
1.6%
1,927,738
$77,514,000 31 Dec 2021
13F
Swedbank AB
13F
Company
1.5%
1,820,000
$73,382,400 31 Dec 2021
13F
GW&K Investment Management, LLC
13F
Company
1.3%
1,558,644
$62,673,000 31 Dec 2021
13F
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
1.3%
1,554,544
$62,508,000 31 Dec 2021
13F
Bank of New York Mellon Corp
13F
Company
1.2%
1,540,266
$61,936,000 31 Dec 2021
13F
First Light Asset Management, LLC
13F
Company
1.2%
1,511,843
$60,791,000 31 Dec 2021
13F
TRAN CAPITAL MANAGEMENT, L.P.
13F
Company
1.2%
1,499,576
$60,298,000 31 Dec 2021
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
1%
1,294,615
$52,057,000 31 Dec 2021
13F
Stephens Investment Management Group LLC
13F
Company
1%
1,274,679
$51,255,000 31 Dec 2021
13F
EAGLE ASSET MANAGEMENT INC
13F
Company
1%
1,256,542
$50,663,000 31 Dec 2021
13F
NEW YORK STATE COMMON RETIREMENT FUND
13F
Company
1%
1,259,450
$50,642,000 31 Dec 2021
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
0.92%
1,138,363
$45,774,000 31 Dec 2021
13F
THRIVENT FINANCIAL FOR LUTHERANS
13F
Company
0.87%
1,076,833
$43,300,000 31 Dec 2021
13F
Bellevue Group AG
13F
Company
0.86%
1,067,500
$42,924,000 31 Dec 2021
13F
NORGES BANK
13F
Company
0.85%
1,046,198
$42,068,000 31 Dec 2021
13F
Nuveen Asset Management, LLC
13F
Company
0.78%
970,318
$39,016,000 31 Dec 2021
13F
Fisher Asset Management, LLC
13F
Company
0.76%
942,730
$37,907,000 31 Dec 2021
13F
Granite Investment Partners, LLC
13F
Company
0.76%
934,562
$37,579,000 31 Dec 2021
13F
ALLIANCEBERNSTEIN L.P.
13F
Company
0.75%
930,451
$37,413,000 31 Dec 2021
13F
Allspring Global Investments Holdings, LLC
13F
Company
0.72%
889,937
$35,784,000 31 Dec 2021
13F
VICTORY CAPITAL MANAGEMENT INC
13F
Company
0.7%
864,173
$34,748,000 31 Dec 2021
13F
S.c.a. Candriam
13F
Individual
0.57%
705,079
$28,352,000 31 Dec 2021
13F
FMR LLC
13F
Company
0.55%
683,039
$27,464,000 31 Dec 2021
13F
JANUS HENDERSON GROUP PLC
13F
Company
0.54%
671,571
$27,004,000 31 Dec 2021
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.53%
653,857
$26,292,000 31 Dec 2021
13F
AMERIPRISE FINANCIAL INC
13F
Company
0.51%
631,127
$25,376,000 31 Dec 2021
13F
Allianz Asset Management GmbH
13F
Company
0.47%
586,274
$23,575,000 31 Dec 2021
13F
DRIEHAUS CAPITAL MANAGEMENT LLC
13F
Company
0.47%
584,910
$23,519,000 31 Dec 2021
13F
KORNITZER CAPITAL MANAGEMENT INC /KS
13F
Company
0.44%
546,715
$21,983,000 31 Dec 2021
13F
KENNEDY CAPITAL MANAGEMENT LLC
13F
Company
0.44%
539,742
$21,703,000 31 Dec 2021
13F
AMERICAN CENTURY COMPANIES INC
13F
Company
0.41%
509,907
$20,504,000 31 Dec 2021
13F
PRINCIPAL FINANCIAL GROUP INC
13F
Company
0.4%
492,521
$19,805,000 31 Dec 2021
13F
WELLS FARGO & COMPANY/MN
13F
Company
0.39%
481,235
$19,350,000 31 Dec 2021
13F
SEI INVESTMENTS CO
13F
Company
0.36%
443,653
$17,856,000 31 Dec 2021
13F
RHUMBLINE ADVISERS
13F
Company
0.34%
415,414
$16,704,000 31 Dec 2021
13F
EcoR1 Capital, LLC
13F
Company
0.32%
392,000
$15,762,000 31 Dec 2021
13F
MORGAN STANLEY
13F
Company
0.3%
373,637
$15,025,000 31 Dec 2021
13F
Redwood Investments, LLC
13F
Company
0.3%
366,897
$14,753,000 31 Dec 2021
13F

Institutional Holders of HALOZYME THERAPEUTICS, INC. - Common Stock (HALO) as of Q1 2022

As of 31 Mar 2022, HALOZYME THERAPEUTICS, INC. - Common Stock (HALO) was held by 298 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 128,337,653 shares. The largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, Artisan Partners Limited Partnership, STATE STREET CORP, WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC, Invesco Ltd., JPMORGAN CHASE & CO, SNYDER CAPITAL MANAGEMENT L P, GEODE CAPITAL MANAGEMENT, LLC, and MACQUARIE GROUP LTD. This page lists 299 institutional shareholders reporting positions in this security for the Q1 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q1 2022 vs Q4 2021 Across Filers

Q4 2021 holders
314
Q1 2022 holders
298
Holder diff
-16
Investor Q4 2021 Shares Q1 2022 Shares Share Diff Share Chg % Q4 2021 Value $ Q1 2022 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.